The purpose of this agreement is for a capitalization grant which provides funds for the recipient's clean water state revolving fund (CWSRF) program with a primary purpose to address emerging…

The U.S. Environmental Protection Agency (EPA) Region 9 awarded the Hawaii Department of Health a capitalization grant totaling $1,733,000 ($1,647,000 in FFY2025 funds and $86,000 in FFY2023 funds) under the Clean Water State Revolving Fund (CWSRF) program (CFDA 66.458) effective October 1, 2025 through September 30, 2032. This formula grant capitalizes Hawaii's CWSRF program with a primary focus on addressing emerging contaminants—substances and microorganisms including pharmaceuticals, personal care products, industrial chemicals, pesticides, and microplastics that pose newly identified or re-emerging risks to human health and the environment. The recipient will deploy these federal funds to provide low-interest financing to multiple subrecipients for eligible water quality improvement activities under Section 603(c) of the Clean Water Act.

The expected outcomes of this capitalization grant are to establish and manage an effective comprehensive CWSRF program and maintain a self-sustaining revolving fund that improves and protects water quality and public health throughout the state. One documented subaward under this grant provides financing to the City & County of Honolulu Environmental Services for the Honouliuli Wastewater Treatment Plant Phase 1C project, which addresses headworks, biological reactors, solids processing, and miscellaneous infrastructure improvements. The revolving loan fund structure enables loan repayments to generate continued funding availability for future water infrastructure projects across Hawaii.

The purpose of this agreement is for a capitalization grant which provides funds for the recipient's clean water state revolving fund (CWSRF) program with a primary purpose to address emerging contaminants. Emerging contaminants refer to substances and microorganisms, including manufactured or naturally occurring physical, chemical, biological, radiological, or nuclear materials, which are known or anticipated in the environment, that may pose newly identified or RE-emerging risks to human health, aquatic life, or the environment. These substances, microorganisms or materials can include many different types of natural or manufactured chemicals and substances - such as those in some compounds of personal care products, pharmaceuticals, industrial chemicals, pesticides, and microplastics. This agreement provides full federal funds in the amount of $1,647,000 of FFY2025 funds and $86,000 of FFY2023 funds for a total of $1,733,000. Refer to terms and conditions. Activities:the activities are to provide low interest financing to numerous subrecipients for costs eligible under section 603(C) of the clean water act and the primary purpose must be to address emerging contaminants.subrecipient:no subawards are included in this assistance agreement.outcomes:the benefits of this grant will be to capitalize the recipient's CWSRF with a primary focus on emerging contaminants. The expected outcomes are to establish and manage an effective comprehensive CWSRF program and to maintain a self-sustaining revolving fund to improve and protect water quality and public health for citizens throughout the state.